These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11601567)

  • 1. Endocrine and lipid responses to chronic androstenediol-herbal supplementation in 30 to 58 year old men.
    Brown GA; Vukovich MD; Martini ER; Kohut ML; Franke WD; Jackson DA; King DS
    J Am Coll Nutr; 2001 Oct; 20(5):520-8. PubMed ID: 11601567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men.
    Brown GA; Vukovich MD; Martini ER; Kohut ML; Franke WD; Jackson DA; King DS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4074-80. PubMed ID: 11095435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of androstenedione-herbal supplementation on serum sex hormone concentrations in 30- to 59-year-old men.
    Brown GA; Vukovich MD; Martini ER; Kohut ML; Franke WD; Jackson DA; King DS
    Int J Vitam Nutr Res; 2001 Sep; 71(5):293-301. PubMed ID: 11725694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program.
    Broeder CE; Quindry J; Brittingham K; Panton L; Thomson J; Appakondu S; Breuel K; Byrd R; Douglas J; Earnest C; Mitchell C; Olson M; Roy T; Yarlagadda C
    Arch Intern Med; 2000 Nov; 160(20):3093-104. PubMed ID: 11074738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial.
    King DS; Sharp RL; Vukovich MD; Brown GA; Reifenrath TA; Uhl NL; Parsons KA
    JAMA; 1999 Jun; 281(21):2020-8. PubMed ID: 10359391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute resistance exercise does not change the hormonal response to sublingual androstenediol intake.
    Brown GA; McKenzie D
    Eur J Appl Physiol; 2006 Jul; 97(4):404-12. PubMed ID: 16636857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hormonal response to sublingual androstenediol intake in young men.
    Brown GA; Martini ER; Roberts BS; Vukovich MD; King DS
    J Appl Physiol (1985); 2002 Jan; 92(1):142-6. PubMed ID: 11744653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men.
    Brown GA; Vukovich MD; Reifenrath TA; Uhl NL; Parsons KA; Sharp RL; King DS
    Int J Sport Nutr Exerc Metab; 2000 Sep; 10(3):340-59. PubMed ID: 10997957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum testosterone and estradiol concentrations following acute androstenedione ingestion in young women.
    Brown GA; Dewey JC; Brunkhorst JA; Vukovich MD; King DS
    Horm Metab Res; 2004 Jan; 36(1):62-6. PubMed ID: 14983409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men.
    Kohut ML; Thompson JR; Campbell J; Brown GA; Vukovich MD; Jackson DA; King DS
    J Am Coll Nutr; 2003 Oct; 22(5):363-71. PubMed ID: 14559928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of testosterone enanthate on serum lipoproteins in man.
    Anderson RA; Wallace EM; Wu FC
    Contraception; 1995 Aug; 52(2):115-9. PubMed ID: 8536448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression.
    Weber B; Lewicka S; Deuschle M; Colla M; Heuser I
    Psychoneuroendocrinology; 2000 Nov; 25(8):765-71. PubMed ID: 10996472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men.
    Beckham SG; Earnest CP
    Br J Sports Med; 2003 Jun; 37(3):212-8. PubMed ID: 12782545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
    Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
    Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prohormone supplementation in humans: a review.
    Ziegenfuss TN; Berardi JM; Lowery LM
    Can J Appl Physiol; 2002 Dec; 27(6):628-46. PubMed ID: 12501001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo 4-androstene-3,17-dione and 4-androstene-3 beta,17 beta-diol supplementation in young men.
    Earnest CP; Olson MA; Broeder CE; Breuel KF; Beckham SG
    Eur J Appl Physiol; 2000 Feb; 81(3):229-32. PubMed ID: 10638382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.
    Stuenkel CA; Dudley RE; Yen SS
    J Clin Endocrinol Metab; 1991 May; 72(5):1054-9. PubMed ID: 1902483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.